No and Prostanoids Blunt Endothelin-mediated Coronary Vasoconstrictor Influence in Exercising Swine.
From: Experimental Cardiology, Thoraxcenter, Erasmus MC, Univ. Medical Center Rotterdam, Box 1738, 3000DR Rotterdam, The Netherlands. d.merkus@erasmusmc.nl
American journal of physiology. Heart and circulatory physiology
- Publish Date: Nov 2006
- ISSN: 0363-6135
- Volume: 291
- Issue: 5
- Pages: H2075-81
- Medium: Print
- Language: English
- Citation (JAMA): Merkus Daphne, Sorop Oana, Houweling Birgit, et al. No and Prostanoids Blunt Endothelin-mediated Coronary Vasoconstrictor Influence in Exercising Swine.. Am. J. Physiol. Heart Circ. Physiol. Nov 2006;291:H2075-81
Abstract
Withdrawal of the endothelin (ET)-mediated vasoconstrictor influence contributes to metabolic coronary vasodilation during exercise. Because production of nitric oxide (NO) and prostanoids increases with increasing shear stress and because NO and prostanoids are able to modify the release of ET, we hypothesized that the withdrawal of ET-mediated coronary vasoconstriction during exercise is mediated through NO and/or prostanoids. To test this hypothesis, 19 chronically instrumented swine were studied at rest and while running on a treadmill up to 85-90% of maximal heart rate. Blockade of ET(A)/ET(B) receptors with tezosentan resulted in an increase in coronary venous O(2) levels (i.e., in coronary vasodilation) at rest, which waned at increasing levels of exercise intensity. Inhibition of either NO synthase [N(omega)-nitro-l-arginine (l-NNA)] or cyclooxygenase (indomethacin) did not affect the response to tezosentan under resting conditions but unmasked a vasodilator response to tezosentan during exercise. The vasodilator response to tezosentan during exercise increased progressively after combined administration of l-NNA and indomethacin. These findings suggest that NO and prostanoids act synergistically to inhibit the vasoconstrictor influence of ET on the coronary circulation during exercise, thereby facilitating the exercise-induced vasodilation of coronary resistance vessels.
Mesh Headings (Keywords): Animals, Cardiac Output, Cyclooxygenase Inhibitors, Drug Interactions, Endothelins, Exertion, Female, Heart Rate, Indomethacin, Male, Nitric Oxide, Nitroarginine, Oxygen Consumption, Physical Conditioning, Animal, Prostaglandins, Pyridines, Receptors, Endothelin, Sus scrofa, Tetrazoles, Vasoconstriction, Vasoconstrictor Agents, Vasodilator Agents
Check for Full Text / PubMed Unique Identifier (PMID): 16751289
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.